6 days Ago By Defense World Staff
Renaissance Technologies LLC raised its stake in Embecta Corp. (NASDAQ:EMBC – Free Report) by 52.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
The institutional investor owned 68,848 shares of the company’s stock after purchasing an additional 23,748 shares during the period. Renaissance Technologies LLC owned 0.12% of Embecta worth $1,422,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Barclays PLC increased its position in Embecta by 41.1% in the 3rd quarter.
Barclays PLC now owns 97,930 shares of the company’s stock valued at $1,381,000 after buying an additional 28,523 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Embecta during the third quarter worth approximately $217,000. Garden State Investment Advisory Services LLC acquired a new position in shares of Embecta during the third quarter worth approximately $438,000.
JPMorgan Chase & Co. lifted its holdings in shares of Embecta by 1.1% in the 3rd quarter.
JPMorgan Chase & Co. now owns 145,269 shares of the company’s stock worth $2,048,000 after purchasing an additional 1,600 shares in the last quarter. Finally, Principal Financial Group Inc.
grew its position in Embecta by 2.9% in the 4th quarter. Principal Financial Group Inc.
now owns 280,004 shares of the company’s stock valued at $5,782,000 after purchasing an additional 7,887 shares during the period. Institutional investors and hedge funds own 93.83% of the company’s stock.
Insider Buying and SellingIn other Embecta news, Director Milton Mayo Morris sold 3,100 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $16.38, for a total value of $50,778.
00. Following the transaction, the director now directly owns 36,133 shares in the company, valued at $591,858.54.
The trade was a 7.90 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
0.42% of the stock is currently owned by corporate insiders. Embecta Stock Up 3.
7 %EMBC stock opened at $12.32 on Tuesday. The firm has a market capitalization of $716.
21 million, a PE ratio of 12.32, a P/E/G ratio of 0.78 and a beta of 1.
23. Embecta Corp. has a twelve month low of $10.
00 and a twelve month high of $21.48. The stock’s 50 day moving average is $12.
70 and its 200-day moving average is $15.85. Embecta (NASDAQ:EMBC – Get Free Report) last posted its quarterly earnings data on Thursday, February 6th.
The company reported $0.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.
20. Embecta had a net margin of 5.25% and a negative return on equity of 19.
22%. On average, equities research analysts anticipate that Embecta Corp. will post 2.
85 earnings per share for the current fiscal year. Embecta Announces DividendThe firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were given a dividend of $0.
15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 4.
87%. The ex-dividend date was Friday, February 28th. Embecta’s payout ratio is 60.
00%. Analyst Ratings ChangesSeparately, Mizuho started coverage on shares of Embecta in a research note on Thursday, April 10th. They issued a “neutral” rating and a $15.
00 price objective on the stock.Get Our Latest Analysis on EMBCAbout Embecta (Free Report)Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.Featured StoriesFive stocks we like better than EmbectaWhat Does a Gap Up Mean in Stocks? How to Play the GapBest Defense Stocks in 2025..
. So FarWhat is a SEC Filing?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementWhat Are Trending Stocks? Trending Stocks ExplainedCould Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?.
